GRN and breast carcinoma: Breast cancer patients showed increased GP88 serum levels having mean levels of 40.7 to 45.3 ng/mL compared to 28.7 ng/mL for age-matched healthy volunteers, with no significantly different expression due to age or ethnicity [9].